| Name | Title | Contact Details |
|---|
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Worldwide provider and innovator in the fields of wellness, beauty, rejuvenation and transformation across the globe at sea on cruise ships and on land.
HealthPort combines technology and strategic solutions to continually improve fragmented business processes for the healthcare community. The company offers revenue cycle management, electronic medical record, electronic document management, document
3LAB Inc is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shawnee Mission Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Shawnee Mission Medical Center is based in Overland Park, KS. You can find more information on Shawnee Mission Medical Center at www.shawneemission.org